Baxter International Inc. (NYSE:BAX) put aside $200 million in equity to invest in early-stage companies that “complement” its portfolio.
The newly established ” Baxter Ventures will invest globally and focus on innovative technologies with sustainable long-term growth” under the watch of the Deerfield, Ill.-based company’s chief scientific officer Norbert Riedel, according to a press release.
To read the full, original article click on this link: Baxter Ventures will invest $200 million in early-stage companies
